{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T20:22:00Z","timestamp":1793823720119,"version":"4.6.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:00:00Z","timestamp":1742860800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:00:00Z","timestamp":1742860800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-84165-x","type":"journal-article","created":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T02:39:59Z","timestamp":1742956799000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The causal impact of body mass index on metabolic biomarkers and nonalcoholic fatty liver disease risk"],"prefix":"10.1038","volume":"15","author":[{"given":"Bo","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjiang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoqiang","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,25]]},"reference":[{"issue":"10290","key":"84165_CR1","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","volume":"397","author":"EE Powell","year":"2021","unstructured":"Powell, E. E., Wong, V. W. S. & Rinella, M. Non-alcoholic fatty liver disease. Lancet 397(10290), 2212\u20132224 (2021).","journal-title":"Lancet"},{"issue":"7","key":"84165_CR2","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1053\/j.gastro.2020.01.052","volume":"158","author":"TG Cotter","year":"2020","unstructured":"Cotter, T. G., & Rinella, M. Nonalcoholic fatty liver Disease 2020: the state of the Disease. Gastroenterology 158(7), 1851\u20131864 (2020).","journal-title":"Gastroenterology"},{"issue":"2","key":"84165_CR3","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jhep.2023.03.040","volume":"79","author":"MH Le","year":"2023","unstructured":"Le, M. H. et al. Global incidence of non-alcoholic fatty liver disease: a systematic review and meta-analysis of 63 studies and 1,201,807 persons. J. Hepatol. 79(2), 287\u2013295 (2023).","journal-title":"J. Hepatol."},{"issue":"3","key":"84165_CR4","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.jhep.2023.04.036","volume":"79","author":"VWS Wong","year":"2023","unstructured":"Wong, V. W. S., Ekstedt, M., Wong, G. L. H. & Hagstr\u00f6m, H. Changing epidemiology, global trends and implications for outcomes of NAFLD. J. Hepatol. 79(3), 842\u2013852 (2023).","journal-title":"J. Hepatol."},{"issue":"9","key":"84165_CR5","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","volume":"7","author":"K Riazi","year":"2022","unstructured":"Riazi, K. et al. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. Lancet Gastroenterol. Hepatol. 7(9), 851\u2013861 (2022).","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"5","key":"84165_CR6","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.3748\/wjg.v21.i5.1650","volume":"21","author":"Q Pang","year":"2015","unstructured":"Pang, Q. et al. Central obesity and nonalcoholic fatty liver disease risk after adjusting for body mass index. World J. Gastroenterol. WJG. 21(5), 1650 (2015).","journal-title":"World J. Gastroenterol. WJG"},{"key":"84165_CR7","doi-asserted-by":"crossref","first-page":"101092","DOI":"10.1016\/j.molmet.2020.101092","volume":"42","author":"A Deprince","year":"2020","unstructured":"Deprince, A., Haas, J. T. & Staels, B. Dysregulated lipid metabolism links NAFLD to cardiovascular disease. Mol. Metabolism. 42, 101092 (2020).","journal-title":"Mol. Metabolism"},{"issue":"8","key":"84165_CR8","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","volume":"65","author":"E Buzzetti","year":"2016","unstructured":"Buzzetti, E., Pinzani, M. & Tsochatzis, E. A. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism 65(8), 1038\u20131048 (2016).","journal-title":"Metabolism"},{"issue":"3","key":"84165_CR9","first-page":"79","volume":"1","author":"CO Demirtas","year":"2020","unstructured":"Demirtas, C. O. & Yilmaz, Y. Metabolic-associated fatty liver disease: time to integrate ground-breaking new terminology to our clinical practice? Hepatol. Forum. 1(3), 79\u201381 (2020).","journal-title":"Hepatol. Forum"},{"issue":"1","key":"84165_CR10","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","volume":"73","author":"M Eslam","year":"2020","unstructured":"Eslam, M. et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J. Hepatol. 73(1), 202\u2013209 (2020).","journal-title":"J. Hepatol."},{"issue":"10","key":"84165_CR11","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/S2468-1253(21)00183-7","volume":"6","author":"M Eslam","year":"2021","unstructured":"Eslam, M. et al. Defining paediatric metabolic (dysfunction)-associated fatty liver disease: an international expert consensus statement. Lancet Gastroenterol. Hepatol. 6(10), 864\u2013873 (2021).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"84165_CR12","doi-asserted-by":"crossref","unstructured":"Emdin, C. A., Khera, A. V., Kathiresan, S. Mendelian Randomization. JAMA ;318(19):1925\u20131926. (2017).","DOI":"10.1001\/jama.2017.17219"},{"issue":"2","key":"84165_CR13","doi-asserted-by":"crossref","first-page":"e3001547","DOI":"10.1371\/journal.pbio.3001547","volume":"20","author":"TG Richardson","year":"2022","unstructured":"Richardson, T. G. et al. Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation. PLoS Biol. 20(2), e3001547 (2022).","journal-title":"PLoS Biol."},{"issue":"39","key":"84165_CR14","doi-asserted-by":"crossref","first-page":"8806","DOI":"10.3748\/wjg.v22.i39.8806","volume":"22","author":"XJ Yang","year":"2016","unstructured":"Yang, X. J. et al. Epidemiological study: correlation between diet habits and constipation among elderly in Beijing region. World J. Gastroenterol. 22(39), 8806\u20138811 (2016).","journal-title":"World J. Gastroenterol."},{"issue":"3","key":"84165_CR15","doi-asserted-by":"crossref","first-page":"534","DOI":"10.3945\/jn.109.118570","volume":"140","author":"R Holma","year":"2010","unstructured":"Holma, R., Hongisto, S-M., Saxelin, M. & Korpela, R. Constipation is relieved more by rye bread than wheat bread or laxatives without increased adverse gastrointestinal effects1,2. J. Nutr. 140(3), 534\u2013541 (2010).","journal-title":"J. Nutr."},{"issue":"R1","key":"84165_CR16","doi-asserted-by":"crossref","first-page":"R89","DOI":"10.1093\/hmg\/ddu328","volume":"23","author":"G Davey Smith","year":"2014","unstructured":"Davey Smith, G. & Hemani, G. Mendelian randomization: genetic anchors for causal inference in epidemiological studies. Hum. Mol. Genet. 23(R1), R89\u2013R98 (2014).","journal-title":"Hum. Mol. Genet."},{"issue":"6","key":"84165_CR17","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1093\/ije\/dyx102","volume":"46","author":"FP Hartwig","year":"2017","unstructured":"Hartwig, F. P., Davey Smith, G. & Bowden, J. Robust inference in summary data mendelian randomization via the zero modal pleiotropy assumption. Int. J. Epidemiol. 46(6), 1985\u20131998 (2017).","journal-title":"Int. J. Epidemiol."},{"issue":"8","key":"84165_CR18","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.jclinepi.2014.03.012","volume":"67","author":"ME Glickman","year":"2014","unstructured":"Glickman, M. E., Rao, S. R. & Schultz, M. R. False discovery rate control is a recommended alternative to Bonferroni-type adjustments in health studies. J. Clin. Epidemiol. 67(8), 850\u2013857 (2014).","journal-title":"J. Clin. Epidemiol."},{"key":"84165_CR19","doi-asserted-by":"crossref","first-page":"e34408","DOI":"10.7554\/eLife.34408","volume":"7","author":"G Hemani","year":"2018","unstructured":"Hemani, G. et al. The MR-Base platform supports systematic causal inference across the human phenome. Elife 7, e34408 (2018).","journal-title":"Elife"},{"key":"84165_CR20","first-page":"111","volume-title":"Obesity, Fatty Liver and Liver Cancer","author":"LHS Lau","year":"2018","unstructured":"Lau, L. H. S., Wong, S. H. & Microbiota Obesity and NAFLD. In: (ed Yu, J.) Obesity, Fatty Liver and Liver Cancer. Singapore: Springer Singapore; 111\u2013125. (2018)."},{"issue":"1","key":"84165_CR21","first-page":"1","volume":"8","author":"M Alves-Bezerra","year":"2017","unstructured":"Alves-Bezerra, M. & Cohen, D. E. Triglyceride metabolism in the liver. Compr. Physiol. 8(1), 1 (2017).","journal-title":"Compr. Physiol."},{"issue":"5","key":"84165_CR22","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41574-019-0156-z","volume":"15","author":"EE Canfora","year":"2019","unstructured":"Canfora, E. E., Meex, R. C. R., Venema, K. & Blaak, E. E. Gut microbial metabolites in obesity, NAFLD and T2DM. Nat. Rev. Endocrinol. 15(5), 261\u2013273 (2019).","journal-title":"Nat. Rev. Endocrinol."},{"issue":"2","key":"84165_CR23","doi-asserted-by":"crossref","first-page":"101","DOI":"10.4161\/21623945.2014.978662","volume":"4","author":"CL Gentile","year":"2015","unstructured":"Gentile, C. L. et al. The role of visceral and subcutaneous adipose tissue fatty acid composition in liver pathophysiology associated with NAFLD. Adipocyte 4(2), 101\u2013112 (2015).","journal-title":"Adipocyte"},{"issue":"2","key":"84165_CR24","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/hep.23280","volume":"51","author":"E Fabbrini","year":"2010","unstructured":"Fabbrini, E., Sullivan, S. & Klein, S. Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology 51(2), 679\u2013689 (2010).","journal-title":"Hepatology"},{"issue":"9","key":"84165_CR25","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/j.bbadis.2015.05.015","volume":"1852","author":"G Arguello","year":"2015","unstructured":"Arguello, G., Balboa, E., Arrese, M. & Zanlungo, S. Recent insights on the role of cholesterol in non-alcoholic fatty liver disease. Biochim. et Biophys. Acta (BBA) - Mol. Basis Dis. 1852(9), 1765\u20131778 (2015).","journal-title":"Biochim. Biophys. Acta (BBA) Mol. Basis Dis"},{"issue":"1","key":"84165_CR26","first-page":"925807","volume":"2012","author":"M Enjoji","year":"2012","unstructured":"Enjoji, M., Yasutake, K., Kohjima, M. & Nakamuta, M. Nutrition and nonalcoholic fatty liver disease: the significance of cholesterol. Int. J. Hepatol. 2012(1), 925807 (2012).","journal-title":"Int. J. Hepatol."},{"issue":"9","key":"84165_CR27","doi-asserted-by":"crossref","first-page":"JITC65","DOI":"10.7326\/IsTranslatedFrom_AITC201811060_Japanese","volume":"169","author":"XJ Wang","year":"2018","unstructured":"Wang, X. J. & Malhi, H. Nonalcoholic fatty liver disease (Japanese Version). Ann. Intern. Med. 169(9), JITC65\u2013JITC80 (2018).","journal-title":"Ann. Intern. Med."},{"issue":"2","key":"84165_CR28","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/MED.0000000000000464","volume":"26","author":"AJ Amor","year":"2019","unstructured":"Amor, A. J. & Perea, V. Dyslipidemia in nonalcoholic fatty liver disease. Curr. Opin. Endocrinol. Diabetes Obes. 26(2), 103\u2013108 (2019).","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"issue":"3","key":"84165_CR29","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/hep.32728","volume":"77","author":"J Xie","year":"2023","unstructured":"Xie, J. et al. The associations between modifiable risk factors and nonalcoholic fatty liver disease: a comprehensive mendelian randomization study. Hepatology 77(3), 949\u2013964 (2023).","journal-title":"Hepatology"},{"issue":"3","key":"84165_CR30","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.metabol.2010.03.006","volume":"60","author":"SC Kalhan","year":"2011","unstructured":"Kalhan, S. C. et al. Plasma metabolomic profile in nonalcoholic fatty liver disease. Metabolism 60(3), 404\u2013413 (2011).","journal-title":"Metabolism"},{"issue":"1","key":"84165_CR31","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/hep.29465","volume":"67","author":"M Gaggini","year":"2018","unstructured":"Gaggini, M. et al. Altered amino acid concentrations in NAFLD: impact of obesity and insulin resistance. Hepatology 67(1), 145\u2013158 (2018).","journal-title":"Hepatology"},{"issue":"7","key":"84165_CR32","doi-asserted-by":"crossref","first-page":"642","DOI":"10.3390\/nu9070642","volume":"9","author":"M Goffredo","year":"2017","unstructured":"Goffredo, M. et al. A branched-chain amino acid-related metabolic signature characterizes obese adolescents with non-alcoholic fatty liver disease. Nutrients 9(7), 642 (2017).","journal-title":"Nutrients"},{"issue":"5","key":"84165_CR33","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.3390\/nu12051450","volume":"12","author":"T Hasegawa","year":"2020","unstructured":"Hasegawa, T. et al. Changed amino acids in NAFLD and liver fibrosis: a large cross-sectional study without influence of insulin resistance. Nutrients 12(5), 1450 (2020).","journal-title":"Nutrients"},{"issue":"10","key":"84165_CR34","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/s41575-022-00635-5","volume":"19","author":"M Eslam","year":"2022","unstructured":"Eslam, M. et al. Metabolic (dysfunction)-associated fatty liver disease in individuals of normal weight. Nat. Rev. Gastroenterol. Hepatol. 19(10), 638\u2013651 (2022).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"8","key":"84165_CR35","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S2468-1253(20)30090-X","volume":"5","author":"M Eslam","year":"2020","unstructured":"Eslam, M., Fan, J-G. & Mendez-Sanchez, N. Non-alcoholic fatty liver disease in non-obese individuals: the impact of metabolic health. Lancet Gastroenterol. Hepatol. 5(8), 713\u2013715 (2020).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"84165_CR36","unstructured":"MH Z. MAFLD: what is different from NAFLD? Clinical and Molecular Hepatology. (2022)."},{"issue":"3","key":"84165_CR37","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1093\/ajcn\/nqab392","volume":"115","author":"Y Pang","year":"2022","unstructured":"Pang, Y. et al. Adiposity, metabolomic biomarkers, and risk of nonalcoholic fatty liver disease: a case-cohort study. Am. J. Clin. Nutr. 115(3), 799\u2013810 (2022).","journal-title":"Am. J. Clin. Nutr."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-84165-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-84165-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-84165-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T02:40:48Z","timestamp":1742956848000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-84165-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,25]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["84165"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-84165-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,25]]},"assertion":[{"value":"10 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics committee approval was not required for this study, as the analysis utilized publicly available data from open-access databases, and no individual-level data was involved.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10314"}}